Related Experiment Videos
[Non-pharmacologic treatment of atrial fibrillation]
Zoltán Csanádi1, Tamás Fazekas, András Varró
1Szegedi Tudományegyetem, Szent-Györgyi Albert Orvos- és Gyógyszerésztudományi Centrum, Altalános Orvostudományi Kar, II. Belgyógyászati Klinika és Kardiológiai Központ. csanadi@in2nd.szote.u-szeged.hu
Abstract:
The authors provide an update on non-pharmacological treatment of atrial fibrillation (AF). They emphasize that although antiarrhythmic drugs continue to be first-line therapy for the arrhythmia considered to be a cardiovascular epidemic, clinical research to develop non-pharmacological means of treatment has been unprecedentally intensified during the last decade. Electrical cardioversion is the most successful non-pharmacological method to restore sinus rhythm, also the efficacy and safety of AV node ablation for palliative ventricular rate-controll is established. "Hybrid" therapeutic procedures, involving combinations of pharmacological and non-pharmacological interventions have gained widespread use. Curative transcatheter ablation for arrhythmia prevention is to be considered in case of clinical suggestions that AF is initiated by a primary regular arrhythmia that is amenable to routine catheter ablation (secondary AF). Despite encouraging results, at this point in time, curative catheter ablation for primary AF may offer significant improvement or even cure only for a small subset of patients, mostly young individuals with normal heart, and paroxysmal AF with frequent, symptomatic episodes refractory to multiple antiarrhythmic drugs. These interventions are to be performed in the settings of a clinical research project in some institutions. Regarding pacemaker therapy in case of bradycardia indication, physiologic pacing (AAI or DDD) is associated with significantly lower incidence of atrial fibrillation than ventricular pacing. Large-scale randomized controlled trials are needed to assess the clinical value of specially designed implantable devices to prevent atrial fibrillation in patients with no conventional bradycardia indication. Also, technical optimization and proper clinical evaluation is needed for implantable atrioverters and implantable cardioverter defibrillators capable of atrial cardioversion therapy.
Insights
Non-pharmacological treatments for atrial fibrillation (AF) are advancing, with electrical cardioversion and AV node ablation showing established efficacy. Research is ongoing for curative catheter ablation and novel implantable devices to manage this cardiovascular epidemic.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Technology
Context:
- Atrial fibrillation (AF) is a widespread arrhythmia, often managed with antiarrhythmic drugs.
- Recent years have seen intensified research into non-pharmacological AF treatments.
- Existing therapies include electrical cardioversion and AV node ablation.
Purpose:
- To review current non-pharmacological treatment options for atrial fibrillation.
- To highlight advancements in therapeutic procedures and emerging technologies.
- To discuss the role of catheter ablation and pacemaker therapy in AF management.
Summary:
- Electrical cardioversion is effective for restoring sinus rhythm.
- AV node ablation provides palliative rate control.
- Hybrid therapies combining drug and non-drug interventions are increasingly used.
- Curative transcatheter ablation shows promise for specific patient subsets, particularly young individuals with paroxysmal AF.
- Physiologic pacing reduces AF incidence compared to ventricular pacing.
- Further research is needed for implantable devices designed to prevent AF.
Impact:
- Provides an update on the evolving landscape of AF treatment beyond traditional drug therapy.
- Identifies areas for future research and clinical evaluation of novel AF interventions.
- Emphasizes the growing importance of interventional procedures and device-based therapies in managing atrial fibrillation.